Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

By sjmartinez • January 7, 2023

Nicholas SB, Alicic RZ, Shen J. Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States. Kidney Med. 2022 Dec 15;5(1):100590. doi: 10.1016/j.xkme.2022.100590. PMID: 36605084; PMCID: PMC9807823.

Tags: Harbor UCLA, Nephrology, Publications

Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study

Abdollahi A, Sani MM, Shabani M, Matuck BS, Blaha MJ, Wu CO, Ambale-Venkatesh B, Budoff MJ, Strom JB, Rotter JI, Post WS, Blumenthal RS, Bluemke[...]

Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study

Karpouzas GA, Ormseth SR, Van Riel P, Myasoedova E, Gonzalez-Gay MA, Corrales A, Rantapaa-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Pascual-Ramos V, Yanez IC,[...]

Bouveret syndrome in 2 parts: endoscopic removal of residual cholelithiasis with closure of cholecystoduodenal fistula after initial surgical management

Cumpian NA, Atla PR, Alao H, Eysselein V, Reicher S. Bouveret syndrome in 2 parts: endoscopic removal of residual cholelithiasis with closure of cholecystoduodenal fistula[...]